{"title":"修整核孔","authors":"Grant Miura","doi":"10.1038/s41589-025-01838-y","DOIUrl":null,"url":null,"abstract":"<p>Molecular glues are small-molecule compounds that promote interactions between a protein of interest and an E3 ubiquitin ligase, leading to selective degradation of the protein of interest. However, these glues are often identified serendipitously through phenotypic screening. Lu et al. have now identified a glue called acepromazine (ACE) that promotes formation of a TRIM21–NUP98 ternary complex, resulting in degradation of nuclear pore proteins. ACE was identified in a chemical screen for compounds that enhance cytotoxicity against the inflammatory cytokine IFNγ. ACE was metabolically converted by aldo-keto reductases into a reduced product called <i>S</i>-ACE-OH. The team performed a genome-wide CRISPR screen and identified the E3 ubiquitin ligase TRIM21 as a key regulator of <i>S</i>-ACE-OH activity. Quantitative proteomic analysis of ACE-sensitive cell lines revealed specific proteosome-mediated depletion of nuclear pore proteins and subsequent fragmentation of the nuclear pore complex structure. CRISPR suppressor scanning screens identified mutations in the nucleoporin NUP98 that increased resistance to ACE-mediated degradation, while isothermal titration calorimetry analysis showed that <i>S</i>-ACE-OH promoted formation of a TRIM21–NUP98 ternary complex. A co-crystal structure of <i>S</i>-ACE-OH with TRIM21 identified a shallow hydrophobic pocket that was potentially ligandable and could enable design of a TRIM21-mediated degrader against the bromodomain of BRD4, which they called TrimTAC. The team observed that a fusion protein consisting of NUP98 with the BRD4 bromodomain could form nuclear condensates in cells, which could then be degraded by the TrimTAC. Fusion of the BRD4 bromodomain to other condensate-forming proteins also resulted in TrimTAC-mediated degradation, with TrimTAC sparing monomeric proteins. Although the biochemical basis of TrimTAC-mediated degradation of multimeric complexes remains unclear, TrimTAC offers intriguing new opportunities to alter condensates.</p><p><b>Original reference:</b> <i>Cell</i> <b>187</b>, 7126–7142 (2024)</p>","PeriodicalId":18832,"journal":{"name":"Nature chemical biology","volume":"38 1","pages":""},"PeriodicalIF":12.9000,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"TRIMming the nuclear pore\",\"authors\":\"Grant Miura\",\"doi\":\"10.1038/s41589-025-01838-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Molecular glues are small-molecule compounds that promote interactions between a protein of interest and an E3 ubiquitin ligase, leading to selective degradation of the protein of interest. However, these glues are often identified serendipitously through phenotypic screening. Lu et al. have now identified a glue called acepromazine (ACE) that promotes formation of a TRIM21–NUP98 ternary complex, resulting in degradation of nuclear pore proteins. ACE was identified in a chemical screen for compounds that enhance cytotoxicity against the inflammatory cytokine IFNγ. ACE was metabolically converted by aldo-keto reductases into a reduced product called <i>S</i>-ACE-OH. The team performed a genome-wide CRISPR screen and identified the E3 ubiquitin ligase TRIM21 as a key regulator of <i>S</i>-ACE-OH activity. Quantitative proteomic analysis of ACE-sensitive cell lines revealed specific proteosome-mediated depletion of nuclear pore proteins and subsequent fragmentation of the nuclear pore complex structure. CRISPR suppressor scanning screens identified mutations in the nucleoporin NUP98 that increased resistance to ACE-mediated degradation, while isothermal titration calorimetry analysis showed that <i>S</i>-ACE-OH promoted formation of a TRIM21–NUP98 ternary complex. A co-crystal structure of <i>S</i>-ACE-OH with TRIM21 identified a shallow hydrophobic pocket that was potentially ligandable and could enable design of a TRIM21-mediated degrader against the bromodomain of BRD4, which they called TrimTAC. The team observed that a fusion protein consisting of NUP98 with the BRD4 bromodomain could form nuclear condensates in cells, which could then be degraded by the TrimTAC. Fusion of the BRD4 bromodomain to other condensate-forming proteins also resulted in TrimTAC-mediated degradation, with TrimTAC sparing monomeric proteins. Although the biochemical basis of TrimTAC-mediated degradation of multimeric complexes remains unclear, TrimTAC offers intriguing new opportunities to alter condensates.</p><p><b>Original reference:</b> <i>Cell</i> <b>187</b>, 7126–7142 (2024)</p>\",\"PeriodicalId\":18832,\"journal\":{\"name\":\"Nature chemical biology\",\"volume\":\"38 1\",\"pages\":\"\"},\"PeriodicalIF\":12.9000,\"publicationDate\":\"2025-01-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature chemical biology\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1038/s41589-025-01838-y\",\"RegionNum\":1,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature chemical biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1038/s41589-025-01838-y","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
Molecular glues are small-molecule compounds that promote interactions between a protein of interest and an E3 ubiquitin ligase, leading to selective degradation of the protein of interest. However, these glues are often identified serendipitously through phenotypic screening. Lu et al. have now identified a glue called acepromazine (ACE) that promotes formation of a TRIM21–NUP98 ternary complex, resulting in degradation of nuclear pore proteins. ACE was identified in a chemical screen for compounds that enhance cytotoxicity against the inflammatory cytokine IFNγ. ACE was metabolically converted by aldo-keto reductases into a reduced product called S-ACE-OH. The team performed a genome-wide CRISPR screen and identified the E3 ubiquitin ligase TRIM21 as a key regulator of S-ACE-OH activity. Quantitative proteomic analysis of ACE-sensitive cell lines revealed specific proteosome-mediated depletion of nuclear pore proteins and subsequent fragmentation of the nuclear pore complex structure. CRISPR suppressor scanning screens identified mutations in the nucleoporin NUP98 that increased resistance to ACE-mediated degradation, while isothermal titration calorimetry analysis showed that S-ACE-OH promoted formation of a TRIM21–NUP98 ternary complex. A co-crystal structure of S-ACE-OH with TRIM21 identified a shallow hydrophobic pocket that was potentially ligandable and could enable design of a TRIM21-mediated degrader against the bromodomain of BRD4, which they called TrimTAC. The team observed that a fusion protein consisting of NUP98 with the BRD4 bromodomain could form nuclear condensates in cells, which could then be degraded by the TrimTAC. Fusion of the BRD4 bromodomain to other condensate-forming proteins also resulted in TrimTAC-mediated degradation, with TrimTAC sparing monomeric proteins. Although the biochemical basis of TrimTAC-mediated degradation of multimeric complexes remains unclear, TrimTAC offers intriguing new opportunities to alter condensates.
期刊介绍:
Nature Chemical Biology stands as an esteemed international monthly journal, offering a prominent platform for the chemical biology community to showcase top-tier original research and commentary. Operating at the crossroads of chemistry, biology, and related disciplines, chemical biology utilizes scientific ideas and approaches to comprehend and manipulate biological systems with molecular precision.
The journal embraces contributions from the growing community of chemical biologists, encompassing insights from chemists applying principles and tools to biological inquiries and biologists striving to comprehend and control molecular-level biological processes. We prioritize studies unveiling significant conceptual or practical advancements in areas where chemistry and biology intersect, emphasizing basic research, especially those reporting novel chemical or biological tools and offering profound molecular-level insights into underlying biological mechanisms.
Nature Chemical Biology also welcomes manuscripts describing applied molecular studies at the chemistry-biology interface due to the broad utility of chemical biology approaches in manipulating or engineering biological systems. Irrespective of scientific focus, we actively seek submissions that creatively blend chemistry and biology, particularly those providing substantial conceptual or methodological breakthroughs with the potential to open innovative research avenues. The journal maintains a robust and impartial review process, emphasizing thorough chemical and biological characterization.